Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 80,200 shares, a growth of 27.7% from the October 15th total of 62,800 shares. Based on an average daily volume of 120,000 shares, the days-to-cover ratio is presently 0.7 days.
Coloplast A/S Stock Performance
Shares of CLPBY traded down $0.10 during midday trading on Friday, reaching $12.78. 91,192 shares of the stock were exchanged, compared to its average volume of 129,191. The firm has a 50 day simple moving average of $13.12 and a 200-day simple moving average of $12.85. The company has a quick ratio of 0.56, a current ratio of 0.85 and a debt-to-equity ratio of 1.00. Coloplast A/S has a 12-month low of $10.61 and a 12-month high of $14.34.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.08 earnings per share for the quarter. The business had revenue of $1.02 billion for the quarter. Coloplast A/S had a net margin of 18.69% and a return on equity of 31.17%. On average, equities research analysts predict that Coloplast A/S will post 0.38 EPS for the current fiscal year.
Coloplast A/S Increases Dividend
About Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.
Further Reading
- Five stocks we like better than Coloplast A/S
- How to Start Investing in Real Estate
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- What Is WallStreetBets and What Stocks Are They Targeting?
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What Are Dividend Contenders? Investing in Dividend Contenders
- Time to Load Up on Home Builders?
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.